60 results
8-K
EX-99.1
1dgn4hzb90g2aejrx
30 Jun 23
Zai Lab and argenx Announce Approval of VYVGART® (efgartigimod alfa injection) for Generalized Myasthenia Gravis in China
4:18pm
8-K
EX-99.1
ats7k50m
9 May 23
Zai Lab Announces First Quarter 2023
4:03pm
8-K
EX-99.1
ey1rrk 4n6w35
9 Aug 22
Zai Lab Announces Second Quarter 2022
12:00am
8-K
EX-99.1
ruu z3n1ny
1 Mar 22
Results of Operations and Financial Condition
4:17pm
8-K
EX-99.1
9abogo
3 Dec 21
Zai Lab Announces Inclusion of ZEJULA® (Niraparib) in China’s National Reimbursement Drug List for First-Line Ovarian Cancer
7:45am